AI Terminal
Novonesis AS
Director's Dealing • Nov 24, 2023
3377_rpt_2023-11-24_92d031d3-32a8-4478-a980-f02b5dfebf32.pdf
Director's Dealing
Open in ViewerOpens in native device viewer
Trading by management and close relations of management
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes reports the following transactions under ISIN DK0060336014, Novozymes B shares under the symbol NZYM B.
November 24, 2023
Company announcement No. 60
Contact information [email protected]
Tobias Cornelius Björklund +45 3077 8682 [email protected]
Anders Enevoldsen +45 5350 1453 [email protected]
About Novozymes
Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com
Novozymes A/S CVR number: 10 00 71 27 LEI: 529900T6WNZXD2R3JW38
Novozymes A/S Krogshoejvej 36 2880 Bagsvaerd
Denmark
Phone: +45 4446 0000
| 1. | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name | Anne Breum | ||
| 2. | Reason for the notification | |||
| a) | Position/status | Member of the Board of Directors | ||
| b) | Initial notification/ Amendment |
Initial notification | ||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||
| a) | Name | Novozymes A/S | ||
| b) | LEI | 529900T6WNZXD2R3JW38 | ||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||
| a) | Description of the financial instrument, type of instrument |
Shares | ||
| Identification code | ISIN DK0060336014 | |||
| b) | Nature of the transaction | Exercise of stock options | ||
| c) | Price(s) and volume(s) | Price(s) DKK: 300.90 |
Volume(s) 137 shares |
|
| d) | Aggregated information - Aggregated volume - Price |
Number of shares: 137 Average price, DKK: 300.90 Transaction value, DKK: 41,223.30 |
||
| e) | Date of transaction | 2023-11-23 | ||
| f) | Place of the transaction | Novozymes' custody account |
| 1. | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name | Anne Breum | ||
| 2. | Reason for the notification | |||
| a) | Position/status | Member of the Board of Directors | ||
| b) | Initial notification/ Amendment |
Initial notification | ||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||
| a) | Name | Novozymes A/S | ||
| b) | LEI | 529900T6WNZXD2R3JW38 | ||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||
| a) | Description of the financial instrument, type of instrument |
Shares | ||
| Identification code | ISIN DK0060336014 | |||
| b) | Nature of the transaction | Sale of shares | ||
| c) | Price(s) and volume(s) | Price(s) DKK: 359.80 |
Volume(s) 137 shares |
|
| d) | Aggregated information - Aggregated volume - Price |
Number of shares: 137 Average price, DKK: 359.80 Transaction value, DKK: 49,292.60 |
||
| e) | Date of transaction | 2023-11-23 | ||
| f) | Place of the transaction | Off Exchange |
